Article info
Original research
Burosumab in management of X-linked hypophosphataemia: a retrospective cohort study of growth and serum phosphate levels
- Correspondence to Dr Wesley Hayes, Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK; Wesley.Hayes{at}gosh.nhs.uk
Citation
Burosumab in management of X-linked hypophosphataemia: a retrospective cohort study of growth and serum phosphate levels
Publication history
- Received September 29, 2022
- Accepted January 9, 2023
- First published January 30, 2023.
Online issue publication
October 18, 2023
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.